AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2020
Aug 12, 2020
31676_dirs_2020-08-12_ceefd4c1-7932-4c6f-b2b1-9e210a4e52b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2020-08-10
Reporting Person: Walsh Patrick D (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-10 | Common Stock | P | 3000 | $30.40 | Acquired | 23096 | Direct |
| 2020-08-10 | Common Stock | P | 4000 | $30.98 | Acquired | 27096 | Direct |
| 2020-08-10 | Common Stock | P | 3000 | $30.89 | Acquired | 30096 | Direct |
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3